Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
retatrutide + cagrilintide Retatrutide alone at 12 mg produced 24-28.7% weight loss in clinical trials
Biologic therapies have transformed Crohn's disease management and include several FDA-approved options: TNF- inhibitors : Infliximab (Remicade), adalimumab (Humira), and certolizumab pegol (Cimzia) block tumor necrosis factor-alpha, a key pro-inflammatory cytokine
There is a clear need for more research in this area
10.1016/j.cej.2025.160293 41 ChelkebaL.AhmadiA.AbdollahiM.NajafiA.GhadimiM
US$ 21.65
US$ 21.18
US$ 26.24
US$ 26.78
